| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR8J3 ABCA1 OR2A7 OXER1 DRD3 HTR2C OR5AK2 OR5V1 HTR7 OR2T35 OR5I1 CYSLTR1 OR9Q2 OR10Q1 TAAR5 OR8H1 OR2T2 OR8K3 OR8J1 GPR101 F2R OR1L3 OR1L1 CHRND OPRK1 OPRL1 OPRM1 GNRHR2 OR1L8 ADORA3 OR4C3 ADRA1A OR10J5 KISS1R OR14A2 OR12D2 P2RY4 CXCR6 LPAR6 OR2A4 OR6J1 MTNR1A C3AR1 OR4K5 OR10J4 OR8D4 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.49e-34 | 1353 | 100 | 52 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR8J3 OR2A7 OXER1 DRD3 HTR2C OR5AK2 OR5V1 HTR7 OR2T35 OR5I1 CYSLTR1 OR9Q2 OR10Q1 TAAR5 OR8H1 OR2T2 OR8K3 OR8J1 GPR101 F2R OR1L3 OR1L1 OPRK1 OPRL1 OPRM1 GNRHR2 OR1L8 ADORA3 OR4C3 ADRA1A OR10J5 KISS1R OR14A2 OR12D2 P2RY4 CXCR6 LPAR6 OR2A4 OR6J1 MTNR1A C3AR1 OR4K5 OR10J4 OR8D4 | 4.43e-33 | 884 | 100 | 44 | GO:0004930 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR6J1 OR4K5 OR10J4 OR8D4 | 9.79e-19 | 431 | 100 | 24 | GO:0004984 |
| GeneOntologyMolecularFunction | odorant binding | OR8J3 OR2A7 OR5AK2 OR5I1 OR9Q2 OR10Q1 OR8H1 OR8K3 OR8J1 OR14A2 OR12D2 OR2A4 OR10J4 OR8D4 | 2.37e-15 | 127 | 100 | 14 | GO:0005549 |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 6.13e-12 | 11 | 100 | 6 | GO:0008503 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | DRD3 HTR2C HTR7 CHRND GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 7.47e-11 | 100 | 100 | 10 | GO:0030594 |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 2.40e-10 | 18 | 100 | 6 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 3.49e-10 | 19 | 100 | 6 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 9.48e-10 | 22 | 100 | 6 | GO:0016917 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.81e-09 | 75 | 100 | 8 | GO:0098960 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.38e-08 | 57 | 100 | 7 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.98e-08 | 60 | 100 | 7 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 3.51e-08 | 65 | 100 | 7 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 3.51e-08 | 65 | 100 | 7 | GO:0022824 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | ANXA6 CHRND KCNT2 TRPM8 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.59e-08 | 193 | 100 | 10 | GO:0015276 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | ANXA6 CHRND KCNT2 TRPM8 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.57e-08 | 197 | 100 | 10 | GO:0022834 |
| GeneOntologyMolecularFunction | gated channel activity | ANXA6 CHRND OPRM1 KCNT2 KCND1 TRPM8 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.11e-07 | 334 | 100 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.15e-07 | 77 | 100 | 7 | GO:0005230 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.80e-07 | 50 | 100 | 6 | GO:0099095 | |
| GeneOntologyMolecularFunction | transporter activity | ABCA1 SPNS2 ANXA6 ATP8B1 SLC30A1 ATP8B2 CHRND OPRM1 SLC5A4 KCNT2 KCND1 ABCD3 TRPM8 SLC30A10 DISP1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.30e-06 | 1289 | 100 | 21 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ANXA6 CHRND OPRM1 KCNT2 KCND1 TRPM8 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.18e-06 | 459 | 100 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 4.20e-06 | 7 | 100 | 3 | GO:0004985 | |
| GeneOntologyMolecularFunction | chloride channel activity | 4.61e-06 | 86 | 100 | 6 | GO:0005254 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCA1 SPNS2 ANXA6 SLC30A1 CHRND OPRM1 SLC5A4 KCNT2 KCND1 ABCD3 TRPM8 SLC30A10 DISP1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.38e-06 | 1180 | 100 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 5.83e-06 | 24 | 100 | 4 | GO:0099507 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 6.70e-06 | 8 | 100 | 3 | GO:0090554 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ANXA6 SLC30A1 CHRND OPRM1 SLC5A4 KCNT2 KCND1 TRPM8 SLC30A10 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 9.22e-06 | 793 | 100 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | channel activity | ANXA6 CHRND OPRM1 KCNT2 KCND1 TRPM8 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.24e-05 | 525 | 100 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ANXA6 CHRND OPRM1 KCNT2 KCND1 TRPM8 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.26e-05 | 526 | 100 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.31e-05 | 103 | 100 | 6 | GO:0005253 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 3.44e-05 | 37 | 100 | 4 | GO:0042923 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.93e-05 | 125 | 100 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 5.20e-05 | 41 | 100 | 4 | GO:0008227 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 5.57e-05 | 133 | 100 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | floppase activity | 6.51e-05 | 16 | 100 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 7.41e-05 | 140 | 100 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | diazepam binding | 7.42e-05 | 3 | 100 | 2 | GO:0050809 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC30A1 OPRM1 SLC5A4 KCNT2 KCND1 TRPM8 SLC30A10 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.04e-04 | 758 | 100 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.12e-04 | 151 | 100 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.31e-04 | 20 | 100 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.21e-04 | 171 | 100 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.65e-04 | 28 | 100 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 3.68e-04 | 6 | 100 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 8.74e-04 | 9 | 100 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.13e-03 | 51 | 100 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 2.17e-03 | 14 | 100 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 3.07e-03 | 196 | 100 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | flippase activity | 3.22e-03 | 17 | 100 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 4.45e-03 | 20 | 100 | 2 | GO:0046624 | |
| GeneOntologyMolecularFunction | peptide binding | 5.31e-03 | 318 | 100 | 6 | GO:0042277 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 5.37e-03 | 22 | 100 | 2 | GO:0004993 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 6.11e-03 | 74 | 100 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | zinc ion transmembrane transporter activity | 6.38e-03 | 24 | 100 | 2 | GO:0005385 | |
| GeneOntologyMolecularFunction | G-protein beta-subunit binding | 6.91e-03 | 25 | 100 | 2 | GO:0031681 | |
| GeneOntologyMolecularFunction | outward rectifier potassium channel activity | 8.03e-03 | 27 | 100 | 2 | GO:0015271 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 8.87e-03 | 465 | 100 | 7 | GO:0046873 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR8J3 ABCA1 OR2A7 OXER1 DRD3 HTR2C OR5AK2 OR5V1 HTR7 OR2T35 OR5I1 CYSLTR1 SPNS2 OR9Q2 OR10Q1 TAAR5 OR8H1 OR2T2 OR8K3 OR8J1 GPR101 F2R OR1L3 OR1L1 OPRK1 OPRL1 OPRM1 GNRHR2 OR1L8 ADORA3 OR4C3 ADRA1A OR10J5 KISS1R OR14A2 OR12D2 P2RY4 CXCR6 LPAR6 OR2A4 OR6J1 MTNR1A C3AR1 OR4K5 OR10J4 OR8D4 | 5.16e-28 | 1395 | 98 | 46 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 SYT10 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR6J1 OR4K5 OR10J4 OR8D4 | 1.05e-19 | 465 | 98 | 25 | GO:0007608 |
| GeneOntologyBiologicalProcess | sensory perception | OR8J3 OR2A7 OR5AK2 OR5V1 HTR7 OR2T35 OR5I1 SPNS2 OR9Q2 OR10Q1 TAAR5 OR8H1 OR2T2 OR8K3 ATP8B1 OR8J1 F2R SYT10 OR1L3 OR1L1 OPRK1 OPRL1 OPRM1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR6J1 TRPM8 OR4K5 OR10J4 OR8D4 | 1.33e-19 | 1072 | 98 | 34 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR6J1 OR4K5 OR10J4 OR8D4 | 2.98e-19 | 432 | 98 | 24 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 TAAR5 OR8H1 OR2T2 OR8K3 OR8J1 SYT10 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR6J1 OR4K5 OR10J4 OR8D4 | 3.70e-19 | 547 | 98 | 26 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR6J1 OR4K5 OR10J4 OR8D4 | 4.27e-18 | 485 | 98 | 24 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR8J3 OR2A7 OR5AK2 OR5V1 HTR7 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR6J1 OR4K5 OR10J4 OR8D4 | 2.19e-17 | 582 | 98 | 25 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR6J1 OR4K5 OR10J4 OR8D4 | 2.49e-17 | 524 | 98 | 24 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR8J3 OR2A7 OR5AK2 OR5V1 HTR7 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR6J1 OR4K5 OR10J4 OR8D4 | 3.25e-15 | 722 | 98 | 25 | GO:0051606 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | DRD3 HTR2C PSEN2 HTR7 SLC30A1 F2R SYT10 CHRND OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 LNPEP GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.34e-10 | 931 | 98 | 22 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | DRD3 HTR2C PSEN2 HTR7 SLC30A1 F2R SYT10 CHRND OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 LNPEP GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.34e-10 | 931 | 98 | 22 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | DRD3 HTR2C PSEN2 HTR7 SLC30A1 F2R SYT10 CHRND OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 LNPEP GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.92e-10 | 939 | 98 | 22 | GO:0099537 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | DRD3 HTR2C PSEN2 HTR7 CYSLTR1 ANXA6 ATP8B1 SLC30A1 F2R ATP8B2 CHRND OPRK1 OPRM1 SLC5A4 ADRA1A KCNT2 P2RY4 KCND1 TRPM8 SLC30A10 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 7.36e-10 | 1374 | 98 | 26 | GO:0006811 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 7.64e-10 | 133 | 98 | 10 | GO:0007200 | |
| GeneOntologyBiologicalProcess | synaptic signaling | DRD3 HTR2C PSEN2 HTR7 SLC30A1 F2R SYT10 CHRND OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 LNPEP GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 8.09e-10 | 976 | 98 | 22 | GO:0099536 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | DRD3 HTR2C PSEN2 ANXA6 ATP8B1 SLC30A1 F2R ATP8B2 CHRND OPRK1 OPRM1 SLC5A4 ADRA1A KCNT2 KCND1 TRPM8 SLC30A10 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.72e-09 | 1115 | 98 | 23 | GO:0034220 |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 5.33e-09 | 30 | 98 | 6 | GO:1904862 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 1.43e-08 | 35 | 98 | 6 | GO:0007214 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 6.10e-08 | 74 | 98 | 7 | GO:0051932 | |
| GeneOntologyBiologicalProcess | chloride transport | 1.74e-07 | 128 | 98 | 8 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | DRD3 HTR2C PSEN2 SLC30A1 F2R OPRK1 OPRM1 SLC5A4 ADRA1A KCNT2 KCND1 TRPM8 SLC30A10 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.65e-07 | 1017 | 98 | 19 | GO:0098660 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | ABCA1 OXER1 DRD3 HTR7 GPR101 OPRK1 OPRL1 OPRM1 ADRA1A MTNR1A | 1.07e-06 | 286 | 98 | 10 | GO:0007188 |
| GeneOntologyBiologicalProcess | inorganic anion transport | 2.32e-06 | 180 | 98 | 8 | GO:0015698 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 2.32e-06 | 180 | 98 | 8 | GO:0060078 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 2.63e-06 | 183 | 98 | 8 | GO:0006820 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 3.41e-06 | 86 | 98 | 6 | GO:0007193 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 1.05e-05 | 61 | 98 | 5 | GO:0007187 | |
| GeneOntologyBiologicalProcess | signal release | ABCA1 DRD3 HTR2C HTR7 SLC30A1 F2R SYT10 OPRK1 OPRM1 ADORA3 KISS1R P2RY4 MTNR1A | 1.29e-05 | 653 | 98 | 13 | GO:0023061 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.57e-05 | 112 | 98 | 6 | GO:1902476 | |
| GeneOntologyBiologicalProcess | G protein-coupled opioid receptor signaling pathway | 2.87e-05 | 13 | 98 | 3 | GO:0038003 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 3.56e-05 | 191 | 98 | 7 | GO:0007189 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 4.33e-05 | 134 | 98 | 6 | GO:0098661 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting opioid receptor signaling pathway | 6.68e-05 | 3 | 98 | 2 | GO:0031635 | |
| GeneOntologyBiologicalProcess | detoxification of zinc ion | 6.68e-05 | 3 | 98 | 2 | GO:0010312 | |
| GeneOntologyBiologicalProcess | stress response to zinc ion | 6.68e-05 | 3 | 98 | 2 | GO:1990359 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | DRD3 HTR2C PSEN2 HTR7 SLC30A1 F2R OPRM1 ADORA3 ADRA1A KISS1R P2RY4 LNPEP | 7.17e-05 | 663 | 98 | 12 | GO:0050804 |
| GeneOntologyBiologicalProcess | metal ion transport | DRD3 HTR2C PSEN2 CYSLTR1 ANXA6 SLC30A1 F2R OPRK1 OPRM1 SLC5A4 ADRA1A KCNT2 KCND1 TRPM8 SLC30A10 | 7.27e-05 | 1000 | 98 | 15 | GO:0030001 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | DRD3 HTR2C PSEN2 HTR7 SLC30A1 F2R OPRM1 ADORA3 ADRA1A KISS1R P2RY4 LNPEP | 7.27e-05 | 664 | 98 | 12 | GO:0099177 |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 7.30e-05 | 214 | 98 | 7 | GO:1903531 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 9.06e-05 | 153 | 98 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 9.71e-05 | 224 | 98 | 7 | GO:0007204 | |
| GeneOntologyBiologicalProcess | regulation of vasoconstriction | 1.05e-04 | 98 | 98 | 5 | GO:0019229 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | DRD3 HTR2C PSEN2 CYSLTR1 ANXA6 SLC30A1 F2R CHRND OPRK1 OPRM1 SLC5A4 ADRA1A KCNT2 KCND1 TRPM8 SLC30A10 | 1.06e-04 | 1157 | 98 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | positive regulation of vasoconstriction | 1.26e-04 | 54 | 98 | 4 | GO:0045907 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 1.45e-04 | 105 | 98 | 5 | GO:0019233 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion | 1.45e-04 | 239 | 98 | 7 | GO:0051048 | |
| GeneOntologyBiologicalProcess | calcium ion transport | DRD3 HTR2C PSEN2 CYSLTR1 ANXA6 SLC30A1 F2R OPRM1 ADRA1A TRPM8 | 1.54e-04 | 509 | 98 | 10 | GO:0006816 |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | DRD3 HTR2C HTR7 SLC30A1 F2R SYT10 OPRK1 OPRM1 ADORA3 KISS1R P2RY4 MTNR1A | 2.00e-04 | 740 | 98 | 12 | GO:1903530 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 2.22e-04 | 25 | 98 | 3 | GO:0071880 | |
| GeneOntologyBiologicalProcess | monoamine transport | 2.31e-04 | 116 | 98 | 5 | GO:0015844 | |
| GeneOntologyBiologicalProcess | cellular response to dopamine | 2.45e-04 | 64 | 98 | 4 | GO:1903351 | |
| GeneOntologyBiologicalProcess | blood circulation | DRD3 HTR2C PSEN2 HTR7 CYSLTR1 F2R OPRL1 ADORA3 ADRA1A LNPEP C3AR1 | 2.54e-04 | 648 | 98 | 11 | GO:0008015 |
| GeneOntologyBiologicalProcess | response to dopamine | 2.76e-04 | 66 | 98 | 4 | GO:1903350 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 2.79e-04 | 266 | 98 | 7 | GO:0019722 | |
| GeneOntologyBiologicalProcess | vasoconstriction | 2.81e-04 | 121 | 98 | 5 | GO:0042310 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 2.92e-04 | 67 | 98 | 4 | GO:0099171 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 3.08e-04 | 358 | 98 | 8 | GO:0015850 | |
| GeneOntologyBiologicalProcess | cellular response to monoamine stimulus | 3.09e-04 | 68 | 98 | 4 | GO:0071868 | |
| GeneOntologyBiologicalProcess | cellular response to catecholamine stimulus | 3.09e-04 | 68 | 98 | 4 | GO:0071870 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 3.14e-04 | 359 | 98 | 8 | GO:0006874 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 3.15e-04 | 124 | 98 | 5 | GO:0007218 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CHRND OPRM1 ADRA1A KCND1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.26e-04 | 559 | 98 | 10 | GO:0042391 |
| GeneOntologyBiologicalProcess | negative regulation of luteinizing hormone secretion | 3.31e-04 | 6 | 98 | 2 | GO:0033685 | |
| GeneOntologyBiologicalProcess | conditioned place preference | 3.31e-04 | 6 | 98 | 2 | GO:1990708 | |
| GeneOntologyBiologicalProcess | export from cell | ABCA1 DRD3 HTR2C HTR7 SLC30A1 F2R SYT10 OPRK1 OPRM1 ADORA3 KISS1R KCNT2 P2RY4 MTNR1A SLC30A10 | 3.44e-04 | 1153 | 98 | 15 | GO:0140352 |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | DRD3 HTR2C RB1CC1 GPR101 F2R OPRK1 OPRM1 ADRA1A KISS1R SLC30A10 | 3.85e-04 | 571 | 98 | 10 | GO:0043410 |
| GeneOntologyBiologicalProcess | response to catecholamine | 4.06e-04 | 73 | 98 | 4 | GO:0071869 | |
| GeneOntologyBiologicalProcess | regulation of secretion | DRD3 HTR2C HTR7 SLC30A1 F2R SYT10 OPRK1 OPRM1 ADORA3 KISS1R P2RY4 MTNR1A | 4.11e-04 | 801 | 98 | 12 | GO:0051046 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | DRD3 HTR2C PSEN2 SLC30A1 F2R OPRK1 OPRM1 SLC5A4 ADRA1A KCNT2 KCND1 TRPM8 SLC30A10 | 4.16e-04 | 922 | 98 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | reproductive behavior | 4.27e-04 | 74 | 98 | 4 | GO:0019098 | |
| GeneOntologyBiologicalProcess | response to monoamine | 4.27e-04 | 74 | 98 | 4 | GO:0071867 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | DRD3 HTR2C PSEN2 SLC30A1 F2R OPRK1 OPRM1 SLC5A4 ADRA1A KCNT2 KCND1 TRPM8 SLC30A10 | 5.10e-04 | 942 | 98 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 5.35e-04 | 389 | 98 | 8 | GO:0055074 | |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 6.10e-04 | 35 | 98 | 3 | GO:0071875 | |
| GeneOntologyBiologicalProcess | circulatory system process | DRD3 HTR2C PSEN2 HTR7 CYSLTR1 F2R OPRL1 ADORA3 ADRA1A LNPEP C3AR1 | 7.15e-04 | 733 | 98 | 11 | GO:0003013 |
| GeneOntologyBiologicalProcess | export across plasma membrane | 9.33e-04 | 91 | 98 | 4 | GO:0140115 | |
| GeneOntologyBiologicalProcess | regulation of blood pressure | 9.43e-04 | 237 | 98 | 6 | GO:0008217 | |
| GeneOntologyBiologicalProcess | regulation of luteinizing hormone secretion | 9.81e-04 | 10 | 98 | 2 | GO:0033684 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 1.14e-03 | 96 | 98 | 4 | GO:0051937 | |
| GeneOntologyBiologicalProcess | serotonin receptor signaling pathway | 1.20e-03 | 11 | 98 | 2 | GO:0007210 | |
| GeneOntologyBiologicalProcess | zinc ion import into organelle | 1.20e-03 | 11 | 98 | 2 | GO:0062111 | |
| GeneOntologyBiologicalProcess | negative regulation of gonadotropin secretion | 1.20e-03 | 11 | 98 | 2 | GO:0032277 | |
| GeneOntologyBiologicalProcess | regulation of Rho protein signal transduction | 1.23e-03 | 98 | 98 | 4 | GO:0035023 | |
| GeneOntologyBiologicalProcess | response to histamine | 1.43e-03 | 12 | 98 | 2 | GO:0034776 | |
| GeneOntologyBiologicalProcess | negative regulation of protein secretion | 1.48e-03 | 103 | 98 | 4 | GO:0050709 | |
| GeneOntologyBiologicalProcess | secretion by cell | ABCA1 DRD3 HTR2C HTR7 SLC30A1 F2R SYT10 OPRK1 OPRM1 ADORA3 KISS1R P2RY4 MTNR1A | 1.56e-03 | 1064 | 98 | 13 | GO:0032940 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating dopamine receptor signaling pathway | 1.68e-03 | 13 | 98 | 2 | GO:0007191 | |
| GeneOntologyBiologicalProcess | luteinizing hormone secretion | 1.96e-03 | 14 | 98 | 2 | GO:0032275 | |
| GeneOntologyBiologicalProcess | negative regulation of cAMP-mediated signaling | 1.96e-03 | 14 | 98 | 2 | GO:0043951 | |
| GeneOntologyBiologicalProcess | learning or memory | 2.02e-03 | 373 | 98 | 7 | GO:0007611 | |
| GeneOntologyBiologicalProcess | response to morphine | 2.25e-03 | 15 | 98 | 2 | GO:0043278 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 2.28e-03 | 55 | 98 | 3 | GO:0045332 | |
| GeneOntologyCellularComponent | synaptic membrane | DRD3 PSEN2 HTR7 SLC30A1 F2R CHRND OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A P2RY4 KCND1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.52e-11 | 583 | 100 | 19 | GO:0097060 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 2.66e-10 | 19 | 100 | 6 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 5.27e-10 | 21 | 100 | 6 | GO:1902710 | |
| GeneOntologyCellularComponent | postsynaptic membrane | DRD3 HTR7 SLC30A1 F2R CHRND OPRK1 OPRM1 ADRA1A KCND1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 8.90e-10 | 405 | 100 | 15 | GO:0045211 |
| GeneOntologyCellularComponent | dendrite membrane | 8.87e-09 | 56 | 100 | 7 | GO:0032590 | |
| GeneOntologyCellularComponent | presynaptic membrane | PSEN2 HTR7 OPRK1 OPRM1 ADORA3 ADRA1A P2RY4 GABRA2 GABRA3 GABRA5 GABRA6 | 9.05e-08 | 277 | 100 | 11 | GO:0042734 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 9.33e-08 | 164 | 100 | 9 | GO:0098982 | |
| GeneOntologyCellularComponent | neuron projection membrane | 1.31e-07 | 82 | 100 | 7 | GO:0032589 | |
| GeneOntologyCellularComponent | chloride channel complex | 3.07e-07 | 57 | 100 | 6 | GO:0034707 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | DRD3 SLC30A1 CHRND GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.25e-07 | 201 | 100 | 9 | GO:0099634 |
| GeneOntologyCellularComponent | leading edge membrane | 6.79e-05 | 210 | 100 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | presynapse | PSEN2 HTR7 RABAC1 SYT10 OPRK1 OPRM1 ADORA3 ADRA1A P2RY4 SLC30A10 GABRA2 GABRA3 GABRA5 GABRA6 | 8.12e-05 | 886 | 100 | 14 | GO:0098793 |
| GeneOntologyCellularComponent | postsynapse | DRD3 HTR7 SLC30A1 F2R CHRND OPRK1 OPRM1 ADRA1A KCND1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 9.68e-05 | 1018 | 100 | 15 | GO:0098794 |
| GeneOntologyCellularComponent | dendrite | HTR2C HTR7 SLC30A1 OPRK1 OPRM1 ADORA3 KCND1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.25e-04 | 858 | 100 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | somatodendritic compartment | HTR2C PSEN2 HTR7 SLC30A1 OPRK1 OPRM1 ADORA3 KCND1 LNPEP MTNR1A GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.29e-04 | 1228 | 100 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | dendritic tree | HTR2C HTR7 SLC30A1 OPRK1 OPRM1 ADORA3 KCND1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.30e-04 | 860 | 100 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | transporter complex | ATP8B1 ATP8B2 CHRND KCND1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.04e-04 | 550 | 100 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 4.65e-04 | 378 | 100 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | receptor complex | HTR2C GPR101 CHRND MTNR1A GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.68e-04 | 581 | 100 | 10 | GO:0043235 |
| GeneOntologyCellularComponent | T-tubule | 5.63e-04 | 79 | 100 | 4 | GO:0030315 | |
| GeneOntologyCellularComponent | postsynaptic specialization | DRD3 SLC30A1 CHRND GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 6.90e-04 | 503 | 100 | 9 | GO:0099572 |
| GeneOntologyCellularComponent | exocytic vesicle | 8.75e-04 | 320 | 100 | 7 | GO:0070382 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.09e-03 | 431 | 100 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MON2 SPNS2 ANXA6 SLC30A1 SYT10 OPRK1 CD1B LNPEP NBEAL2 CD58 C3AR1 PCDH7 SLC30A10 GABRA1 GABRA2 | 1.35e-03 | 1307 | 100 | 15 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | MON2 SPNS2 ANXA6 SLC30A1 SYT10 OPRK1 CD1B LNPEP NBEAL2 CD58 C3AR1 PCDH7 SLC30A10 GABRA1 GABRA2 | 1.55e-03 | 1325 | 100 | 15 | GO:0012506 |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 1.99e-03 | 14 | 100 | 2 | GO:1990531 | |
| GeneOntologyCellularComponent | sarcolemma | 2.21e-03 | 190 | 100 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | mitotic spindle midzone | 2.60e-03 | 16 | 100 | 2 | GO:1990023 | |
| GeneOntologyCellularComponent | synaptic vesicle | 3.21e-03 | 300 | 100 | 6 | GO:0008021 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.62e-03 | 523 | 100 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 4.92e-03 | 22 | 100 | 2 | GO:0098691 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 6.23e-03 | 78 | 100 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | secretory vesicle | PSEN2 HTR7 RABAC1 SYT10 OPRK1 FRK LNPEP NBEAL2 CD58 C3AR1 PCDH7 SLC30A10 GABRA2 | 6.39e-03 | 1246 | 100 | 13 | GO:0099503 |
| GeneOntologyCellularComponent | neuronal cell body | PSEN2 HTR7 OPRK1 OPRM1 KCND1 LNPEP MTNR1A GABRA2 GABRA5 GABRA6 | 6.64e-03 | 835 | 100 | 10 | GO:0043025 |
| GeneOntologyCellularComponent | nuclear membrane | 6.65e-03 | 349 | 100 | 6 | GO:0031965 | |
| MousePheno | impaired behavioral response to xenobiotic | 2.50e-09 | 83 | 61 | 8 | MP:0009747 | |
| MousePheno | abnormal GABA-mediated receptor currents | 1.10e-08 | 18 | 61 | 5 | MP:0004008 | |
| MousePheno | impaired behavioral response to morphine | 6.76e-08 | 10 | 61 | 4 | MP:0009757 | |
| MousePheno | abnormal behavioral response to morphine | 2.28e-07 | 13 | 61 | 4 | MP:0020159 | |
| MousePheno | abnormal behavioral response to xenobiotic | DRD3 HTR2C HTR7 OPRK1 OPRL1 OPRM1 GABRA1 GABRA2 GABRA4 GABRA5 | 8.01e-07 | 309 | 61 | 10 | MP:0009745 |
| MousePheno | abnormal behavioral response to anesthetic | 1.69e-05 | 12 | 61 | 3 | MP:0009777 | |
| MousePheno | abnormal touch/ nociception | 3.37e-05 | 376 | 61 | 9 | MP:0001968 | |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | ABCA1 DRD3 HIVEP2 HTR2C HTR7 SPNS2 ATP8B1 OPRK1 OPRL1 OPRM1 ADORA3 MAPK15 ABCD3 TRPM8 GABRA1 GABRA2 GABRA3 GABRA4 | 4.06e-05 | 1486 | 61 | 18 | MP:0002067 |
| MousePheno | impaired behavioral response to addictive substance | 4.28e-05 | 45 | 61 | 4 | MP:0009750 | |
| MousePheno | abnormal associative learning | 4.76e-05 | 393 | 61 | 9 | MP:0002062 | |
| MousePheno | decreased chemically-elicited antinociception | 7.29e-05 | 19 | 61 | 3 | MP:0001982 | |
| MousePheno | abnormal thermal nociception | 8.86e-05 | 168 | 61 | 6 | MP:0002733 | |
| MousePheno | abnormal pain threshold | 1.55e-04 | 267 | 61 | 7 | MP:0001970 | |
| MousePheno | impaired behavioral response to anesthetic | 1.86e-04 | 5 | 61 | 2 | MP:0009778 | |
| MousePheno | enhanced behavioral response to anesthetic | 1.86e-04 | 5 | 61 | 2 | MP:0009779 | |
| MousePheno | enhanced behavioral response to xenobiotic | 2.29e-04 | 69 | 61 | 4 | MP:0009746 | |
| MousePheno | abnormal chemically-elicited antinociception | 2.66e-04 | 29 | 61 | 3 | MP:0001980 | |
| MousePheno | enhanced conditioning behavior | 2.70e-04 | 72 | 61 | 4 | MP:0012316 | |
| MousePheno | increased coping response | 5.09e-04 | 36 | 61 | 3 | MP:0003063 | |
| Domain | 7tm_1 | OR8J3 OR2A7 OXER1 DRD3 HTR2C OR5AK2 OR5V1 HTR7 OR2T35 OR5I1 CYSLTR1 OR9Q2 OR10Q1 TAAR5 OR8H1 OR2T2 OR8K3 OR8J1 GPR101 F2R OR1L3 OR1L1 OPRK1 OPRL1 OPRM1 GNRHR2 OR1L8 ADORA3 OR4C3 ADRA1A OR10J5 KISS1R OR12D2 P2RY4 CXCR6 LPAR6 OR2A4 OR6J1 MTNR1A C3AR1 OR4K5 OR8D4 | 4.33e-35 | 677 | 96 | 42 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR8J3 OR2A7 OXER1 DRD3 HTR2C OR5AK2 OR5V1 HTR7 OR2T35 OR5I1 CYSLTR1 OR9Q2 OR10Q1 TAAR5 OR8H1 OR2T2 OR8K3 OR8J1 GPR101 F2R OR1L3 OR1L1 OPRK1 OPRL1 OPRM1 GNRHR2 OR1L8 ADORA3 OR4C3 ADRA1A OR10J5 KISS1R OR12D2 P2RY4 CXCR6 LPAR6 OR2A4 OR6J1 MTNR1A C3AR1 OR4K5 OR8D4 | 7.04e-35 | 685 | 96 | 42 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR8J3 OR2A7 OXER1 DRD3 HTR2C OR5AK2 OR5V1 HTR7 OR2T35 OR5I1 CYSLTR1 OR9Q2 OR10Q1 TAAR5 OR8H1 OR2T2 OR8K3 OR8J1 GPR101 F2R OR1L3 OR1L1 OPRK1 OPRL1 OPRM1 GNRHR2 OR1L8 ADORA3 OR4C3 ADRA1A OR10J5 KISS1R OR12D2 P2RY4 CXCR6 LPAR6 OR2A4 OR6J1 MTNR1A C3AR1 OR4K5 OR8D4 | 1.01e-34 | 691 | 96 | 42 | PS50262 |
| Domain | GPCR_Rhodpsn | OR8J3 OR2A7 OXER1 DRD3 HTR2C OR5AK2 OR5V1 HTR7 OR2T35 OR5I1 CYSLTR1 OR9Q2 OR10Q1 TAAR5 OR8H1 OR2T2 OR8K3 OR8J1 GPR101 F2R OR1L3 OR1L1 OPRK1 OPRL1 OPRM1 GNRHR2 OR1L8 ADORA3 OR4C3 ADRA1A OR10J5 KISS1R OR12D2 P2RY4 CXCR6 LPAR6 OR2A4 OR6J1 MTNR1A C3AR1 OR4K5 OR8D4 | 1.07e-34 | 692 | 96 | 42 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR8J3 OR2A7 OXER1 DRD3 HTR2C OR5AK2 OR5V1 HTR7 OR2T35 OR5I1 CYSLTR1 OR9Q2 OR10Q1 TAAR5 OR8H1 OR2T2 OR8K3 OR8J1 GPR101 F2R OR1L3 OR1L1 OPRK1 OPRL1 OPRM1 OR1L8 ADORA3 OR4C3 ADRA1A OR10J5 KISS1R OR12D2 P2RY4 CXCR6 LPAR6 OR2A4 MTNR1A C3AR1 OR4K5 OR8D4 | 1.29e-32 | 670 | 96 | 40 | IPR017452 |
| Domain | Olfact_rcpt | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR12D2 OR2A4 OR6J1 OR4K5 OR8D4 | 4.59e-17 | 393 | 96 | 22 | IPR000725 |
| Domain | GABAAa_rcpt | 1.57e-14 | 6 | 96 | 6 | IPR001390 | |
| Domain | GABAA/Glycine_rcpt | 1.48e-09 | 23 | 96 | 6 | IPR006028 | |
| Domain | Neurotransmitter_ion_chnl_CS | 2.94e-09 | 45 | 96 | 7 | IPR018000 | |
| Domain | Neur_chan_memb | 3.45e-09 | 46 | 96 | 7 | PF02932 | |
| Domain | Neur_chan_LBD | 4.04e-09 | 47 | 96 | 7 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 4.04e-09 | 47 | 96 | 7 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 4.04e-09 | 47 | 96 | 7 | IPR006029 | |
| Domain | - | 4.04e-09 | 47 | 96 | 7 | 2.70.170.10 | |
| Domain | Neur_channel | 4.04e-09 | 47 | 96 | 7 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 4.04e-09 | 47 | 96 | 7 | IPR006202 | |
| Domain | 7TM_GPCR_Srsx | 6.07e-09 | 112 | 96 | 9 | SM01381 | |
| Domain | Opioid_rcpt | 5.24e-07 | 4 | 96 | 3 | IPR001418 | |
| Domain | Cation_efflux | 1.15e-03 | 10 | 96 | 2 | IPR002524 | |
| Domain | Cation_efflux | 1.15e-03 | 10 | 96 | 2 | PF01545 | |
| Domain | - | 1.40e-03 | 11 | 96 | 2 | 1.20.1510.10 | |
| Domain | Cation_efflux_TMD | 1.40e-03 | 11 | 96 | 2 | IPR027469 | |
| Domain | P_typ_ATPase_c | 2.29e-03 | 14 | 96 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 2.29e-03 | 14 | 96 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 2.29e-03 | 14 | 96 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 2.29e-03 | 14 | 96 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 2.29e-03 | 14 | 96 | 2 | PF16209 | |
| Domain | - | 1.17e-02 | 32 | 96 | 2 | 3.40.1110.10 | |
| Domain | - | 1.17e-02 | 32 | 96 | 2 | 2.70.150.10 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | DRD3 HTR2C HTR7 CYSLTR1 TAAR5 F2R CHRND OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 LPAR6 MTNR1A C3AR1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.11e-19 | 272 | 94 | 23 | M13380 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR6J1 OR4K5 OR10J4 OR8D4 | 2.28e-16 | 417 | 94 | 24 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR8J3 OR2A7 OR5AK2 OR5V1 OR5I1 OR9Q2 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR12D2 OR2A4 OR4K5 OR8D4 | 8.41e-13 | 389 | 94 | 20 | M14091 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | DRD3 HTR2C OR5V1 HTR7 OR5I1 CYSLTR1 F2R OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A P2RY4 LPAR6 OR2A4 MTNR1A C3AR1 | 1.16e-12 | 260 | 94 | 17 | M39397 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR6J1 OR4K5 OR10J4 OR8D4 | 2.46e-12 | 636 | 94 | 24 | M41834 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | OXER1 DRD3 HTR2C HTR7 CYSLTR1 TAAR5 F2R OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 CXCR6 LPAR6 MTNR1A C3AR1 | 5.04e-12 | 330 | 94 | 18 | M18334 |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 6.18e-12 | 9 | 94 | 6 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 1.54e-11 | 10 | 94 | 6 | M477 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | DRD3 HTR2C HTR7 CYSLTR1 F2R OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A OR10J5 P2RY4 MTNR1A C3AR1 | 2.06e-11 | 186 | 94 | 14 | MM15994 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | DRD3 HTR2C HTR7 CYSLTR1 TAAR5 F2R OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 CXCR6 LPAR6 MTNR1A C3AR1 | 5.99e-11 | 333 | 94 | 17 | MM14963 |
| Pathway | WP_GPCRS_NONODORANT | DRD3 HTR2C HTR7 CYSLTR1 F2R OPRK1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 CXCR6 LPAR6 MTNR1A C3AR1 | 2.27e-10 | 266 | 94 | 15 | MM15843 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | OXER1 DRD3 HTR2C HTR7 CYSLTR1 TAAR5 F2R OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 CXCR6 LPAR6 MTNR1A C3AR1 | 1.28e-09 | 463 | 94 | 18 | M507 |
| Pathway | BIOCARTA_GABA_PATHWAY | 2.91e-09 | 10 | 94 | 5 | MM1401 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD3 HTR2C HTR7 CYSLTR1 TAAR5 F2R OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 CXCR6 LPAR6 MTNR1A C3AR1 | 3.05e-09 | 430 | 94 | 17 | MM15160 |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 4.81e-08 | 31 | 94 | 6 | M39369 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | OXER1 DRD3 HTR2C HTR7 CYSLTR1 TAAR5 F2R OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 CXCR6 ARHGEF10 LPAR6 MTNR1A C3AR1 | 1.48e-07 | 702 | 94 | 19 | M746 |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 1.74e-07 | 38 | 94 | 6 | M39854 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD3 HTR2C HTR7 CYSLTR1 TAAR5 F2R OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A KISS1R P2RY4 CXCR6 ARHGEF10 LPAR6 MTNR1A C3AR1 | 2.16e-07 | 646 | 94 | 18 | MM14962 |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.80e-06 | 60 | 94 | 6 | M976 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.80e-06 | 60 | 94 | 6 | MM15708 | |
| Pathway | WP_GPCRS_OTHER | 3.44e-06 | 96 | 94 | 7 | MM15939 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 8.29e-06 | 42 | 94 | 5 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 8.29e-06 | 42 | 94 | 5 | MM14971 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 1.43e-05 | 119 | 94 | 7 | M48309 | |
| Pathway | WP_GPCRS_OTHER | 3.58e-05 | 93 | 94 | 6 | M39629 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | OXER1 DRD3 OPRK1 OPRL1 OPRM1 ADORA3 P2RY4 CXCR6 MTNR1A C3AR1 | 4.50e-05 | 314 | 94 | 10 | M600 |
| Pathway | WP_NUCLEOTIDE_GPCRS | 4.56e-05 | 11 | 94 | 3 | M39422 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.89e-05 | 144 | 94 | 7 | MM14501 | |
| Pathway | WP_MONOAMINE_GPCRS | 5.08e-05 | 31 | 94 | 4 | MM15871 | |
| Pathway | WP_NUCLEOTIDE_GPCRS | 6.05e-05 | 12 | 94 | 3 | MM15953 | |
| Pathway | WP_MONOAMINE_GPCRS | 6.54e-05 | 33 | 94 | 4 | M39585 | |
| Pathway | WP_GPCRS_PEPTIDE | 1.02e-04 | 70 | 94 | 5 | MM15959 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.31e-04 | 289 | 94 | 9 | MM15057 | |
| Pathway | WP_PEPTIDE_GPCRS | 1.41e-04 | 75 | 94 | 5 | M39696 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 1.51e-04 | 16 | 94 | 3 | M6786 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 1.51e-04 | 16 | 94 | 3 | MM15050 | |
| Pathway | WP_SEROTONIN_AND_ANXIETY | 1.82e-04 | 17 | 94 | 3 | M39511 | |
| Pathway | WP_SEROTONIN_AND_ANXIETY | 1.82e-04 | 17 | 94 | 3 | MM15861 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 3.38e-04 | 50 | 94 | 4 | M47951 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 3.43e-04 | 197 | 94 | 7 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 3.43e-04 | 197 | 94 | 7 | MM14970 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.36e-04 | 205 | 94 | 7 | M752 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.18e-04 | 211 | 94 | 7 | MM14502 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 7.55e-04 | 367 | 94 | 9 | M48346 | |
| Pathway | WP_PURINERGIC_SIGNALING | 1.36e-03 | 33 | 94 | 3 | M39855 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.66e-03 | 411 | 94 | 9 | M735 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.77e-03 | 335 | 94 | 8 | MM14503 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.17e-03 | 270 | 94 | 7 | M15514 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 2.33e-03 | 11 | 94 | 2 | MM15049 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 2.33e-03 | 11 | 94 | 2 | MM15008 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 2.78e-03 | 12 | 94 | 2 | M10960 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 2.78e-03 | 12 | 94 | 2 | M6034 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 2.79e-03 | 210 | 94 | 6 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 3.28e-03 | 217 | 94 | 6 | M18437 | |
| Pathway | WP_GPCRS_ODORANT | 3.98e-03 | 157 | 94 | 5 | MM15872 | |
| Pathway | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | 4.37e-03 | 15 | 94 | 2 | M10620 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR8K3 OR8J1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR4K5 OR8D4 | 3.10e-19 | 340 | 101 | 19 | 11875048 |
| Pubmed | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR8K3 OR8J1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR4K5 OR8D4 | 3.10e-19 | 340 | 101 | 19 | 11802173 | |
| Pubmed | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR8K3 OR8J1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR4K5 OR8D4 | 3.65e-19 | 343 | 101 | 19 | 32295537 | |
| Pubmed | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR9Q2 OR10Q1 OR8H1 OR8K3 OR8J1 OR1L8 OR4C3 OR10J5 OR14A2 OR12D2 OR2A4 OR4K5 OR8D4 | 4.30e-19 | 346 | 101 | 19 | 14611657 | |
| Pubmed | 4.85e-18 | 13 | 101 | 8 | 22569571 | ||
| Pubmed | 4.85e-18 | 13 | 101 | 8 | 22640814 | ||
| Pubmed | OR8J3 OR2A7 OR5AK2 OR5V1 OR2T35 OR5I1 OR10Q1 OR8H1 OR2T2 OR8K3 OR8J1 OR1L3 OR1L1 OR1L8 OR4C3 OR10J5 OR12D2 OR2A4 OR4K5 OR8D4 | 1.01e-16 | 541 | 101 | 20 | 14983052 | |
| Pubmed | OXER1 DRD3 HTR7 F2R OPRK1 OPRL1 OPRM1 GNRHR2 ADORA3 P2RY4 CXCR6 LPAR6 MTNR1A C3AR1 | 1.90e-16 | 179 | 101 | 14 | 18577758 | |
| Pubmed | 5.16e-16 | 6 | 101 | 6 | 20457185 | ||
| Pubmed | DRD3 HTR2C HTR7 TAAR5 OPRK1 OPRL1 OPRM1 GNRHR2 ADORA3 ADRA1A P2RY4 CXCR6 LPAR6 | 2.66e-14 | 200 | 101 | 13 | 18240029 | |
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 2.36e-13 | 11 | 101 | 6 | 9924185 | |
| Pubmed | 2.24e-12 | 81 | 101 | 9 | 22723691 | ||
| Pubmed | HTR2C HTR7 CHRND OPRK1 OPRM1 GNRHR2 ADORA3 ADRA1A GABRA1 GABRA2 GABRA3 GABRA5 GABRA6 | 4.67e-12 | 300 | 101 | 13 | 19086053 | |
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | DRD3 HTR2C OPRK1 OPRL1 OPRM1 ADRA1A GABRA2 GABRA3 GABRA4 GABRA6 | 5.40e-12 | 130 | 101 | 10 | 19874574 |
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | DRD3 HTR2C HTR7 OPRK1 OPRM1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 6.28e-12 | 182 | 101 | 11 | 20468064 |
| Pubmed | 9.31e-12 | 18 | 101 | 6 | 19078961 | ||
| Pubmed | 1.04e-11 | 8 | 101 | 5 | 8175718 | ||
| Pubmed | 2.70e-11 | 21 | 101 | 6 | 25708312 | ||
| Pubmed | 6.70e-11 | 4 | 101 | 4 | 25865415 | ||
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 8.51e-11 | 11 | 101 | 5 | 38894703 | |
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 3.34e-10 | 5 | 101 | 4 | 30104684 | |
| Pubmed | 3.76e-10 | 58 | 101 | 7 | 11140838 | ||
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 1.00e-09 | 6 | 101 | 4 | 15033447 | |
| Pubmed | 2.33e-09 | 7 | 101 | 4 | 7560270 | ||
| Pubmed | 2.33e-09 | 7 | 101 | 4 | 16101898 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 2.33e-09 | 7 | 101 | 4 | 20843900 | |
| Pubmed | 2.33e-09 | 7 | 101 | 4 | 17021187 | ||
| Pubmed | 2.33e-09 | 7 | 101 | 4 | 35228700 | ||
| Pubmed | Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. | 4.65e-09 | 8 | 101 | 4 | 18185516 | |
| Pubmed | 4.65e-09 | 8 | 101 | 4 | 11528422 | ||
| Pubmed | 1.39e-08 | 10 | 101 | 4 | 36733270 | ||
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 1.39e-08 | 10 | 101 | 4 | 21789198 | |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 16835366 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 15304513 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 1356407 | ||
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 15017002 | ||
| Pubmed | 6.56e-08 | 14 | 101 | 4 | 22768092 | ||
| Pubmed | Identification of a novel family of G protein-coupled receptor associated sorting proteins. | 6.56e-08 | 14 | 101 | 4 | 15086532 | |
| Pubmed | Multiple opioid receptor-like genes are identified in diverse vertebrate phyla. | 9.49e-08 | 4 | 101 | 3 | 8941707 | |
| Pubmed | Association study between GABA receptor genes and anxiety spectrum disorders. | 9.49e-08 | 4 | 101 | 3 | 19842164 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 25080596 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 16176386 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 26518133 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 11430857 | ||
| Pubmed | Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. | 9.49e-08 | 4 | 101 | 3 | 20692323 | |
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 9.49e-08 | 4 | 101 | 3 | 18821008 | |
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 1.00e-07 | 128 | 101 | 7 | 19058789 | |
| Pubmed | 1.99e-07 | 18 | 101 | 4 | 18985723 | ||
| Pubmed | 4.72e-07 | 6 | 101 | 3 | 21751815 | ||
| Pubmed | Functional activity of serotoninergic and melatoninergic systems expressed in the skin. | 4.72e-07 | 6 | 101 | 3 | 12767050 | |
| Pubmed | 8.25e-07 | 7 | 101 | 3 | 16080114 | ||
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 2.57e-06 | 74 | 101 | 5 | 15081110 | |
| Pubmed | 2.75e-06 | 75 | 101 | 5 | 2834384 | ||
| Pubmed | 2.81e-06 | 10 | 101 | 3 | 20583128 | ||
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 3.71e-06 | 219 | 101 | 7 | 12213199 | |
| Pubmed | Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. | 5.13e-06 | 12 | 101 | 3 | 2561974 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23652222 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 7802669 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15695058 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 12574430 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 11378843 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22763624 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 14766194 | ||
| Pubmed | κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage. | 8.35e-06 | 2 | 101 | 2 | 31940240 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15748148 | ||
| Pubmed | Molecular and neuronal substrate for the selective attenuation of anxiety. | 8.35e-06 | 2 | 101 | 2 | 11021797 | |
| Pubmed | Differential involvement of the mu and kappa opioid receptors in spatial learning. | 8.35e-06 | 2 | 101 | 2 | 12884965 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 28512665 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19457072 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18085262 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 25482686 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 24553732 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21073549 | ||
| Pubmed | Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors. | 8.35e-06 | 2 | 101 | 2 | 16954126 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23147414 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23109109 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22666188 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 27155990 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17185983 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19106782 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23744069 | ||
| Pubmed | Functional mapping of GABA A receptor subtypes in the amygdala. | 8.35e-06 | 2 | 101 | 2 | 15341600 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8391122 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 21056629 | ||
| Pubmed | Differential stability of the crystallographic interfaces of mu- and kappa-opioid receptors. | 8.35e-06 | 2 | 101 | 2 | 24651466 | |
| Pubmed | GABRA1 and GABRA6 gene mutations in idiopathic generalized epilepsy patients. | 8.35e-06 | 2 | 101 | 2 | 34740144 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18973555 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16530171 | ||
| Pubmed | GABAA receptor alpha1 and alpha6 subunits mediate cell surface anchoring in cultured cells. | 8.35e-06 | 2 | 101 | 2 | 15196679 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 31056671 | ||
| Pubmed | Elevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease. | 8.35e-06 | 2 | 101 | 2 | 30152845 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 27838450 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 19207358 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22138325 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22882391 | ||
| Pubmed | Reversal of pathological pain through specific spinal GABAA receptor subtypes. | 8.35e-06 | 2 | 101 | 2 | 18202657 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 36469977 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 11140333 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26446222 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 27958613 | ||
| Interaction | GABRA5 interactions | 6.45e-07 | 5 | 82 | 3 | int:GABRA5 | |
| Interaction | EMP1 interactions | 6.72e-06 | 65 | 82 | 5 | int:EMP1 | |
| Interaction | GPRASP1 interactions | 7.81e-06 | 67 | 82 | 5 | int:GPRASP1 | |
| Interaction | TMBIM6 interactions | 9.98e-06 | 121 | 82 | 6 | int:TMBIM6 | |
| Interaction | LPCAT3 interactions | 1.87e-05 | 80 | 82 | 5 | int:LPCAT3 | |
| Interaction | ATP2B3 interactions | 2.65e-05 | 86 | 82 | 5 | int:ATP2B3 | |
| Interaction | SGCB interactions | 2.80e-05 | 87 | 82 | 5 | int:SGCB | |
| Cytoband | 11q12.1 | 7.46e-08 | 161 | 101 | 7 | 11q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 1.03e-06 | 345 | 101 | 8 | chr11q12 | |
| Cytoband | 9q33.2 | 8.92e-05 | 39 | 101 | 3 | 9q33.2 | |
| Cytoband | 2q37.1 | 4.47e-04 | 67 | 101 | 3 | 2q37.1 | |
| Cytoband | 6q23 | 5.64e-04 | 16 | 101 | 2 | 6q23 | |
| Cytoband | 4p12 | 8.87e-04 | 20 | 101 | 2 | 4p12 | |
| Cytoband | 5q33.1 | 1.50e-03 | 26 | 101 | 2 | 5q33.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p12 | 1.50e-03 | 26 | 101 | 2 | chr4p12 | |
| Cytoband | 1q44 | 1.88e-03 | 110 | 101 | 3 | 1q44 | |
| Cytoband | 5q34 | 2.28e-03 | 32 | 101 | 2 | 5q34 | |
| Cytoband | 1q23.2 | 2.72e-03 | 35 | 101 | 2 | 1q23.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 2.89e-03 | 128 | 101 | 3 | chr1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 3.57e-03 | 138 | 101 | 3 | chr9q33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q34 | 3.72e-03 | 41 | 101 | 2 | chr5q34 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 2.88e-10 | 19 | 88 | 6 | 563 | |
| GeneFamily | Opioid receptors | 4.44e-07 | 4 | 88 | 3 | 245 | |
| GeneFamily | Olfactory receptors, family 8 | 3.92e-06 | 49 | 88 | 5 | 155 | |
| GeneFamily | Leukotriene receptors | 3.47e-04 | 6 | 88 | 2 | 204 | |
| GeneFamily | Olfactory receptors, family 1 | 9.66e-04 | 40 | 88 | 3 | 147 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 1.76e-03 | 13 | 88 | 2 | 170 | |
| GeneFamily | Olfactory receptors, family 2 | 2.25e-03 | 113 | 88 | 4 | 149 | |
| GeneFamily | ATPase phospholipid transporting | 2.36e-03 | 15 | 88 | 2 | 1210 | |
| GeneFamily | Olfactory receptors, family 10 | 4.09e-03 | 66 | 88 | 3 | 157 | |
| Coexpression | GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN | 8.49e-06 | 200 | 95 | 7 | M9469 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-06 | 176 | 101 | 6 | ed7ba2a3af3b060dec98b60f09f96000a67f7e63 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.98e-06 | 113 | 101 | 5 | feb3c6a7723263d58e5ce020a0097fedfcf78ca8 | |
| Computational | Genes in the cancer module 289. | 1.05e-07 | 124 | 51 | 8 | MODULE_289 | |
| Computational | Genes in the cancer module 146. | 4.63e-07 | 102 | 51 | 7 | MODULE_146 | |
| Computational | Genes in the cancer module 141. | 7.84e-07 | 16 | 51 | 4 | MODULE_141 | |
| Computational | Vesicular transport / synapse genes. | 2.24e-06 | 82 | 51 | 6 | MODULE_274 | |
| Computational | GPCR signaling pathways (immune and neuro). | 3.87e-06 | 90 | 51 | 6 | MODULE_375 | |
| Computational | Genes in the cancer module 134. | 1.12e-05 | 30 | 51 | 4 | MODULE_134 | |
| Computational | Genes in the cancer module 396. | 2.15e-05 | 12 | 51 | 3 | MODULE_396 | |
| Computational | Neurotransmitter (GABA) receptor. | 4.40e-05 | 15 | 51 | 3 | MODULE_215 | |
| Computational | Ion channels. | 3.27e-04 | 70 | 51 | 4 | MODULE_316 | |
| Computational | Genes in the cancer module 489. | 4.53e-04 | 32 | 51 | 3 | MODULE_489 | |
| Computational | Neighborhood of ARL3 | 5.37e-04 | 304 | 51 | 7 | MORF_ARL3 | |
| Computational | Neighborhood of FOSL1 | 5.91e-04 | 406 | 51 | 8 | MORF_FOSL1 | |
| Computational | Genes in the cancer module 288. | 6.98e-04 | 37 | 51 | 3 | MODULE_288 | |
| Computational | Neighborhood of TFDP2 | 7.24e-04 | 230 | 51 | 6 | MORF_TFDP2 | |
| Computational | Genes in the cancer module 27. | 1.34e-03 | 355 | 51 | 7 | MODULE_27 | |
| Computational | Neighborhood of BNIP1 | 1.99e-03 | 190 | 51 | 5 | MORF_BNIP1 | |
| Computational | Neighborhood of RAD51L3 | 2.19e-03 | 387 | 51 | 7 | MORF_RAD51L3 | |
| Computational | Neighborhood of CASP10 | 2.25e-03 | 117 | 51 | 4 | MORF_CASP10 | |
| Computational | Neighborhood of NOS2A | 2.30e-03 | 288 | 51 | 6 | MORF_NOS2A | |
| Computational | Membranal receptors. | 2.78e-03 | 517 | 51 | 8 | MODULE_64 | |
| Computational | Neighborhood of MAGEA9 | 3.60e-03 | 423 | 51 | 7 | MORF_MAGEA9 | |
| Drug | Meprobamate | 5.80e-15 | 6 | 99 | 6 | DB00371 | |
| Drug | Ethchlorvynol | 4.82e-13 | 9 | 99 | 6 | DB00189 | |
| Drug | Secobarbital | 1.20e-12 | 10 | 99 | 6 | DB00418 | |
| Drug | Chlordiazepoxide | 1.20e-12 | 10 | 99 | 6 | DB00475 | |
| Drug | Metharbital | 1.20e-12 | 10 | 99 | 6 | DB00463 | |
| Drug | Pentobarbital | 1.20e-12 | 10 | 99 | 6 | DB00312 | |
| Drug | Talbutal | 1.20e-12 | 10 | 99 | 6 | DB00306 | |
| Drug | Clobazam | 1.20e-12 | 10 | 99 | 6 | DB00349 | |
| Drug | Butalbital | 1.20e-12 | 10 | 99 | 6 | DB00241 | |
| Drug | Butabarbital | 1.20e-12 | 10 | 99 | 6 | DB00237 | |
| Drug | Bromazepam | 1.20e-12 | 10 | 99 | 6 | DB01558 | |
| Drug | Barbituric acid derivative | 1.20e-12 | 10 | 99 | 6 | DB01496 | |
| Drug | Barbital | 1.20e-12 | 10 | 99 | 6 | DB01483 | |
| Drug | Hexobarbital | 1.20e-12 | 10 | 99 | 6 | DB01355 | |
| Drug | Aprobarbital | 1.20e-12 | 10 | 99 | 6 | DB01352 | |
| Drug | Amobarbital | 1.20e-12 | 10 | 99 | 6 | DB01351 | |
| Drug | Heptabarbital | 1.20e-12 | 10 | 99 | 6 | DB01354 | |
| Drug | Butethal | 1.20e-12 | 10 | 99 | 6 | DB01353 | |
| Drug | Methylphenobarbital | 1.20e-12 | 10 | 99 | 6 | DB00849 | |
| Drug | Oxazepam | 1.20e-12 | 10 | 99 | 6 | DB00842 | |
| Drug | Primidone | 1.20e-12 | 10 | 99 | 6 | DB00794 | |
| Drug | Midazolam | 1.20e-12 | 10 | 99 | 6 | DB00683 | |
| Drug | Flurazepam | 1.20e-12 | 10 | 99 | 6 | DB00690 | |
| Drug | benzodiazepine | HTR2C OPRK1 OPRL1 OPRM1 ADORA3 MTNR1A GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.26e-12 | 142 | 99 | 12 | CID000134664 |
| Drug | Thiopental | 2.63e-12 | 11 | 99 | 6 | DB00599 | |
| Drug | Alprazolam | 2.63e-12 | 11 | 99 | 6 | DB00404 | |
| Drug | Temazepam | 2.63e-12 | 11 | 99 | 6 | DB00231 | |
| Drug | Nitrazepam | 2.63e-12 | 11 | 99 | 6 | DB01595 | |
| Drug | Lorazepam | 2.63e-12 | 11 | 99 | 6 | DB00186 | |
| Drug | Phenobarbital | 2.63e-12 | 11 | 99 | 6 | DB01174 | |
| Drug | Triazolam | 2.63e-12 | 11 | 99 | 6 | DB00897 | |
| Drug | Clorazepate | 2.63e-12 | 11 | 99 | 6 | DB00628 | |
| Drug | phentolamine | DRD3 HTR2C HTR7 CHRND OPRK1 OPRL1 OPRM1 SLC5A4 ADORA3 ADRA1A LNPEP GABRA1 GABRA6 | 4.00e-12 | 200 | 99 | 13 | CID000005775 |
| Drug | Flunitrazepam | 8.39e-12 | 6 | 99 | 5 | DB01544 | |
| Drug | atropine sulfate | DRD3 HTR2C HTR7 CHRND OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.78e-11 | 347 | 99 | 15 | CID000003661 |
| Drug | diazepam | HTR2C TAAR5 OPRK1 OPRL1 OPRM1 ADORA3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 3.71e-11 | 189 | 99 | 12 | CID000003016 |
| Drug | dihydroxyaflavinine | 6.90e-11 | 17 | 99 | 6 | CID000156857 | |
| Drug | AC1Q3ZOL | DRD3 HTR7 CHRND OPRK1 OPRL1 OPRM1 ADORA3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 9.78e-11 | 258 | 99 | 13 | CID000002376 |
| Drug | abecarnil | 1.03e-10 | 18 | 99 | 6 | CID000065914 | |
| Drug | 2-hydroxysaclofen | 1.77e-10 | 59 | 99 | 8 | CID000001564 | |
| Drug | muscimol | DRD3 OPRK1 OPRL1 OPRM1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.44e-10 | 129 | 99 | 10 | CID000004266 |
| Drug | pentobarbital | HTR7 OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 2.67e-10 | 224 | 99 | 12 | CID000004737 |
| Drug | DMCM | 2.68e-10 | 38 | 99 | 7 | CID000104999 | |
| Drug | zaleplon | 3.25e-10 | 39 | 99 | 7 | CID000005719 | |
| Drug | Flumazenil | 3.36e-10 | 4 | 99 | 4 | DB01205 | |
| Drug | AC1L1FKW | 3.48e-10 | 10 | 99 | 5 | CID000003281 | |
| Drug | Clonazepam | 3.48e-10 | 10 | 99 | 5 | DB01068 | |
| Drug | Gabrene | 3.93e-10 | 40 | 99 | 7 | CID005361323 | |
| Drug | gaboxadol | 4.72e-10 | 41 | 99 | 7 | CID000003448 | |
| Drug | tetradotoxin | DRD3 HTR2C HTR7 CHRND OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 5.17e-10 | 428 | 99 | 15 | CID000020382 |
| Drug | adinazolam | 5.51e-10 | 23 | 99 | 6 | CID000037632 | |
| Drug | bretazenil | 5.51e-10 | 23 | 99 | 6 | CID000107926 | |
| Drug | fosazepam | 6.35e-10 | 11 | 99 | 5 | CID000037114 | |
| Drug | C19H18ClN3O | 6.35e-10 | 11 | 99 | 5 | CID000027452 | |
| Drug | flutoprazepam | 6.35e-10 | 11 | 99 | 5 | CID000003400 | |
| Drug | Arfendazam | 6.35e-10 | 11 | 99 | 5 | CID000065803 | |
| Drug | camazepam | 6.35e-10 | 11 | 99 | 5 | CID000037367 | |
| Drug | Bu-1014 | 6.35e-10 | 11 | 99 | 5 | CID015942721 | |
| Drug | Zapizolam | 6.35e-10 | 11 | 99 | 5 | CID000068832 | |
| Drug | Reclazepam | 6.35e-10 | 11 | 99 | 5 | CID003052777 | |
| Drug | iclazepam | 6.35e-10 | 11 | 99 | 5 | CID000068777 | |
| Drug | menitrazepam | 6.35e-10 | 11 | 99 | 5 | CID000189875 | |
| Drug | Serin hydrazid | 6.35e-10 | 11 | 99 | 5 | CID000041637 | |
| Drug | sulazepam | 6.35e-10 | 11 | 99 | 5 | CID000017931 | |
| Drug | elfazepam | 6.35e-10 | 11 | 99 | 5 | CID000065445 | |
| Drug | triflubazam | 6.35e-10 | 11 | 99 | 5 | CID000031157 | |
| Drug | uldazepam | 6.35e-10 | 11 | 99 | 5 | CID000034274 | |
| Drug | gidazepam | 6.35e-10 | 11 | 99 | 5 | CID000121919 | |
| Drug | fletazepam | 6.35e-10 | 11 | 99 | 5 | CID000036834 | |
| Drug | baclofen | DRD3 OPRK1 OPRL1 OPRM1 ADORA3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 7.19e-10 | 191 | 99 | 11 | CID000002284 |
| Drug | alpidem | 7.32e-10 | 24 | 99 | 6 | CID000054897 | |
| Drug | methohexital | 7.32e-10 | 24 | 99 | 6 | CID000009034 | |
| Drug | AC1Q5UBL | HTR2C OPRK1 OPRL1 ADRA1A GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 8.25e-10 | 146 | 99 | 10 | CID000005466 |
| Drug | SB-205384 | 1.09e-09 | 12 | 99 | 5 | CID000197690 | |
| Drug | U-93631 | 1.09e-09 | 12 | 99 | 5 | CID000197626 | |
| Drug | haloxazolam | 1.09e-09 | 12 | 99 | 5 | CID000003563 | |
| Drug | doxefazepam | 1.09e-09 | 12 | 99 | 5 | CID000038668 | |
| Drug | pivoxazepam | 1.09e-09 | 12 | 99 | 5 | CID000068722 | |
| Drug | razobazam | 1.09e-09 | 12 | 99 | 5 | CID000071228 | |
| Drug | acamprosate | 1.14e-09 | 74 | 99 | 8 | CID000071158 | |
| Drug | pitrazepin | 1.59e-09 | 27 | 99 | 6 | CID000146222 | |
| Drug | dopamine | DRD3 HTR2C HTR7 TAAR5 F2R CHRND OPRK1 OPRL1 OPRM1 ADORA3 ADRA1A MTNR1A GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 1.66e-09 | 715 | 99 | 18 | CID000000681 |
| Drug | Eszopiclone | 1.68e-09 | 5 | 99 | 4 | DB00402 | |
| Drug | Zopiclone | 1.68e-09 | 5 | 99 | 4 | DB01198 | |
| Drug | Lorazepam | 1.68e-09 | 5 | 99 | 4 | ctd:D008140 | |
| Drug | nerisopam | 1.76e-09 | 13 | 99 | 5 | CID000065875 | |
| Drug | flutazolam | 1.76e-09 | 13 | 99 | 5 | CID000003398 | |
| Drug | 4-PIOL | 1.76e-09 | 13 | 99 | 5 | CID000125520 | |
| Drug | AC1MVFYM | 1.76e-09 | 13 | 99 | 5 | CID003707225 | |
| Drug | Ro 11-3128 | 1.76e-09 | 13 | 99 | 5 | CID000093364 | |
| Drug | cinolazepam | 1.76e-09 | 13 | 99 | 5 | CID003033621 | |
| Drug | alpha IMGBL | 1.76e-09 | 13 | 99 | 5 | CID000131516 | |
| Drug | metaclazepam | 1.76e-09 | 13 | 99 | 5 | CID000071272 | |
| Drug | beta-CCt | 2.72e-09 | 14 | 99 | 5 | CID000124514 | |
| Drug | Me-lex | 2.72e-09 | 14 | 99 | 5 | CID000004177 | |
| Drug | ethyl loflazepate | 2.72e-09 | 14 | 99 | 5 | CID000003299 | |
| Drug | 3-isothujone | 3.16e-09 | 30 | 99 | 6 | CID000011027 | |
| Drug | flumazenil | 3.55e-09 | 54 | 99 | 7 | CID000003373 | |
| Drug | fluoxetine | DRD3 HTR2C HTR7 CHRND ADRA1A GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 | 4.04e-09 | 225 | 99 | 11 | CID000003386 |
| Drug | SR 95103 | 4.07e-09 | 15 | 99 | 5 | CID000125958 | |
| Disease | Alcoholic Intoxication, Chronic | DRD3 HTR2C HTR7 OPRK1 OPRL1 OPRM1 GABRA1 GABRA2 GABRA5 GABRA6 | 1.49e-08 | 268 | 94 | 10 | C0001973 |
| Disease | Mood Disorders | 1.16e-06 | 168 | 94 | 7 | C0525045 | |
| Disease | Mental Depression | 1.59e-06 | 254 | 94 | 8 | C0011570 | |
| Disease | Cocaine Abuse | 3.37e-06 | 127 | 94 | 6 | C0009171 | |
| Disease | Depressive disorder | 4.13e-06 | 289 | 94 | 8 | C0011581 | |
| Disease | Schizophrenia | ABCA1 DRD3 HTR2C PSEN2 HTR7 RB1CC1 OPRM1 ADRA1A MTNR1A GABRA1 GABRA4 GABRA5 GABRA6 | 4.55e-06 | 883 | 94 | 13 | C0036341 |
| Disease | Visual seizure | 1.83e-05 | 101 | 94 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 1.83e-05 | 101 | 94 | 5 | C0270846 | |
| Disease | Generalized seizures | 1.83e-05 | 101 | 94 | 5 | C0234533 | |
| Disease | Clonic Seizures | 1.83e-05 | 101 | 94 | 5 | C0234535 | |
| Disease | Vertiginous seizure | 1.83e-05 | 101 | 94 | 5 | C0422855 | |
| Disease | Gustatory seizure | 1.83e-05 | 101 | 94 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.83e-05 | 101 | 94 | 5 | C0422850 | |
| Disease | Olfactory seizure | 1.83e-05 | 101 | 94 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 1.83e-05 | 101 | 94 | 5 | C0422852 | |
| Disease | Generalized Absence Seizures | 1.83e-05 | 101 | 94 | 5 | C4505436 | |
| Disease | Convulsive Seizures | 1.83e-05 | 101 | 94 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 1.83e-05 | 101 | 94 | 5 | C0751496 | |
| Disease | Jacksonian Seizure | 1.83e-05 | 101 | 94 | 5 | C0022333 | |
| Disease | Non-epileptic convulsion | 1.83e-05 | 101 | 94 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.83e-05 | 101 | 94 | 5 | C0751123 | |
| Disease | Complex partial seizures | 1.83e-05 | 101 | 94 | 5 | C0149958 | |
| Disease | Single Seizure | 1.83e-05 | 101 | 94 | 5 | C0751110 | |
| Disease | Epileptic Seizures | 1.83e-05 | 101 | 94 | 5 | C4317109 | |
| Disease | Nonepileptic Seizures | 1.83e-05 | 101 | 94 | 5 | C3495874 | |
| Disease | Tonic Seizures | 1.92e-05 | 102 | 94 | 5 | C0270844 | |
| Disease | Absence Seizures | 1.92e-05 | 102 | 94 | 5 | C4316903 | |
| Disease | Convulsions | 1.92e-05 | 102 | 94 | 5 | C4048158 | |
| Disease | Seizures, Focal | 2.11e-05 | 104 | 94 | 5 | C0751495 | |
| Disease | Myoclonic Seizures | 2.11e-05 | 104 | 94 | 5 | C4317123 | |
| Disease | Tonic - clonic seizures | 2.11e-05 | 104 | 94 | 5 | C0494475 | |
| Disease | Alcohol abuse | 6.35e-05 | 67 | 94 | 4 | C0085762 | |
| Disease | Cocaine Dependence | 8.46e-05 | 139 | 94 | 5 | C0600427 | |
| Disease | bipolar disorder (is_implicated_in) | 1.08e-04 | 29 | 94 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | Bipolar Disorder | 1.45e-04 | 477 | 94 | 8 | C0005586 | |
| Disease | Autistic Disorder | 1.92e-04 | 261 | 94 | 6 | C0004352 | |
| Disease | Morphine Abuse | 2.09e-04 | 7 | 94 | 2 | C0600272 | |
| Disease | Morphine Dependence | 2.09e-04 | 7 | 94 | 2 | C0026552 | |
| Disease | Memory Loss | 3.52e-04 | 43 | 94 | 3 | C0751295 | |
| Disease | Age-Related Memory Disorders | 3.52e-04 | 43 | 94 | 3 | C0751292 | |
| Disease | Memory Disorder, Spatial | 3.52e-04 | 43 | 94 | 3 | C0751294 | |
| Disease | Memory Disorder, Semantic | 3.52e-04 | 43 | 94 | 3 | C0751293 | |
| Disease | Memory Disorders | 3.52e-04 | 43 | 94 | 3 | C0025261 | |
| Disease | heroin abuse | 3.56e-04 | 9 | 94 | 2 | C0600241 | |
| Disease | Heroin Dependence | 3.56e-04 | 9 | 94 | 2 | C0019337 | |
| Disease | amnestic disorder (implicated_via_orthology) | 3.56e-04 | 9 | 94 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | Heroin Smoking | 3.56e-04 | 9 | 94 | 2 | C4505390 | |
| Disease | Memory impairment | 3.77e-04 | 44 | 94 | 3 | C0233794 | |
| Disease | Cocaine-Related Disorders | 5.44e-04 | 117 | 94 | 4 | C0236736 | |
| Disease | autistic disorder (is_marker_for) | 6.49e-04 | 12 | 94 | 2 | DOID:12849 (is_marker_for) | |
| Disease | Seizures | 6.77e-04 | 218 | 94 | 5 | C0036572 | |
| Disease | HOMA-B | 7.28e-04 | 55 | 94 | 3 | EFO_0004469 | |
| Disease | Hepatic Encephalopathy | 7.65e-04 | 13 | 94 | 2 | C0019151 | |
| Disease | Hepatic Coma | 7.65e-04 | 13 | 94 | 2 | C0019147 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 7.65e-04 | 13 | 94 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 7.65e-04 | 13 | 94 | 2 | C0751198 | |
| Disease | Withdrawal Symptoms | 8.51e-04 | 58 | 94 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 8.51e-04 | 58 | 94 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 8.51e-04 | 58 | 94 | 3 | C0038587 | |
| Disease | Neuralgia, Supraorbital | 1.17e-03 | 16 | 94 | 2 | C0038870 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 1.17e-03 | 16 | 94 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 1.17e-03 | 16 | 94 | 2 | C0423711 | |
| Disease | Tremor, Rubral | 1.17e-03 | 16 | 94 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.17e-03 | 16 | 94 | 2 | C0750937 | |
| Disease | Neuralgia | 1.17e-03 | 16 | 94 | 2 | C0027796 | |
| Disease | Ataxia, Motor | 1.17e-03 | 16 | 94 | 2 | C0278161 | |
| Disease | alcohol use disorder (is_implicated_in) | 1.17e-03 | 16 | 94 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | Abnormal coordination | 1.17e-03 | 16 | 94 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 1.17e-03 | 16 | 94 | 2 | C0427190 | |
| Disease | Neuralgia, Atypical | 1.17e-03 | 16 | 94 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 1.17e-03 | 16 | 94 | 2 | C0234249 | |
| Disease | Paroxysmal Nerve Pain | 1.17e-03 | 16 | 94 | 2 | C0751373 | |
| Disease | Nerve Pain | 1.17e-03 | 16 | 94 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 1.17e-03 | 16 | 94 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 1.17e-03 | 16 | 94 | 2 | C0042656 | |
| Disease | Ataxia, Sensory | 1.17e-03 | 16 | 94 | 2 | C0240991 | |
| Disease | retinopathy | 1.32e-03 | 17 | 94 | 2 | EFO_0003839 | |
| Disease | Cannabis Dependence | 1.32e-03 | 17 | 94 | 2 | C0006870 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.62e-03 | 157 | 94 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | nose morphology measurement, mouth morphology measurement | 2.03e-03 | 21 | 94 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.23e-03 | 22 | 94 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Etat Marbre | 2.43e-03 | 23 | 94 | 2 | C0266487 | |
| Disease | fasting blood glucose measurement, HOMA-B, fasting blood insulin measurement | 2.87e-03 | 25 | 94 | 2 | EFO_0004465, EFO_0004466, EFO_0004469 | |
| Disease | Cardiac Arrhythmia | 2.87e-03 | 25 | 94 | 2 | C0003811 | |
| Disease | Ataxia | 2.87e-03 | 25 | 94 | 2 | C0004134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLCLFVVTPVMVVGT | 471 | Q07001 | |
| FNVESRILCMLYVPV | 951 | O15013 | |
| FLPLLTMIVCYSVII | 201 | O00574 | |
| IVSLASRMKCIPYSV | 101 | Q9H9Q2 | |
| IFIPLVVMCAIYLDI | 186 | P0DMS8 | |
| PLAIILVMYCRVYVV | 196 | P35348 | |
| CPRTIEVLMNTYSVV | 376 | Q8WXI3 | |
| DMCNYVVPATLVIII | 1706 | O95477 | |
| PLTIMVITYCLTIYV | 226 | P28335 | |
| GIMETVRILLYETCP | 171 | P29016 | |
| LLPSVIMIACYSFIV | 346 | Q16581 | |
| YPAIAIVIVLLVMCV | 506 | Q96F81 | |
| CLLPVVAIRFLSMTI | 1156 | O43520 | |
| LMLAVVKCIRSTPEY | 241 | P08133 | |
| LTTVVCIMPVVAFRF | 1091 | P98198 | |
| VAICNPLLYTVVMSR | 126 | Q13606 | |
| VLAVYSSRLVMVEPV | 931 | O75808 | |
| TVPQMYCLAVVEVVR | 491 | Q8TDY2 | |
| TAVMIIAYHTVCTPR | 1821 | Q8TEM1 | |
| MIQVLYFLEPVRCLI | 531 | Q504Q3 | |
| ICYSSAIIPQMLAVL | 71 | Q8NGE9 | |
| VMPACILVILVSYLF | 206 | Q8NGE9 | |
| DRVVSVLYTVVTPML | 271 | Q8NGE9 | |
| ICSPLLYRVIMSPRV | 126 | Q8NGM9 | |
| LYRVIMSPRVCSLLV | 131 | Q8NGM9 | |
| ITIMALYSIVCVVGL | 71 | P35372 | |
| QLSIMDTIYICITVP | 66 | Q6IF00 | |
| RSVMSLIDVVAILPY | 261 | Q9NSA2 | |
| IPLAVITTCIVLYMN | 221 | P19256 | |
| LSTLYQCIRFPVVAM | 411 | Q8IXH7 | |
| MCTVVDPRIVRRYLL | 1 | Q8TD08 | |
| VYRSVVCPILDEVIM | 81 | P52732 | |
| TYIVAAPMTTRVLII | 26 | A6NM62 | |
| IVLTIVLYPSRVRVM | 181 | Q8WXJ9 | |
| QTYLPCIMTVILSQV | 256 | P47869 | |
| TMIIVAVYCPVIAAV | 56 | Q96RV3 | |
| ICKPLYYVVIMSRRT | 126 | Q8NGD3 | |
| VILIILIVVMARYCR | 891 | O60245 | |
| RCLTKYSQIPSVLVM | 221 | O75616 | |
| PLSVKIVMTYRLCSE | 1401 | Q6ZR08 | |
| SLVIYVICRHKPMRT | 61 | Q969F8 | |
| MALRICVTYTPALPI | 1 | Q96EZ4 | |
| PSARTMVVCAFVIVV | 106 | Q9UIQ6 | |
| AVSVIMVIYLLPRCT | 121 | Q9UIQ6 | |
| QTYLPCIMTVILSQV | 281 | P34903 | |
| QTYLPCIMTVILSQV | 256 | P14867 | |
| IQTYIPCIMTVILSQ | 261 | P48169 | |
| VIQTYLPCIMTVILS | 261 | P31644 | |
| QIYTPCIMTVILSQV | 246 | Q16445 | |
| VYMPTVVLRRTPACA | 136 | Q8TAD2 | |
| VAAVRTMYPITLCIA | 266 | P43657 | |
| YVVILCPTEMDVQVR | 331 | Q6UVM3 | |
| IVIPLIVMIACYSVV | 201 | Q96P66 | |
| YFPICMRLLRVVSVL | 306 | Q7Z3U7 | |
| LVGPLSTIVVSYMCI | 206 | Q96R45 | |
| RIVAIMYTVVTPVLN | 271 | P58182 | |
| QLSIMDTIYICITVP | 66 | Q8NGX2 | |
| ICNPLLYMVVVSRRL | 126 | Q8NGG0 | |
| VLAMVVAVYTICFLP | 296 | Q8TDS5 | |
| VIMTPFSCIIISYLR | 256 | Q8NH94 | |
| LVGPLSTIVVSYMCI | 206 | O95047 | |
| VPLIISTVCYVSIIR | 281 | P25116 | |
| DRLVSVLYSVVTPML | 271 | Q9UGF6 | |
| VPCLVTLVCYGLMAR | 211 | P51582 | |
| ICKPLHYTVIMSRTV | 126 | Q8NH90 | |
| ICNPLLYMVVVSRRL | 126 | Q8NGP2 | |
| CTLEDPIYIITELMR | 296 | P42685 | |
| ICLLVAYITENLMRP | 201 | F2Z333 | |
| CLPYAITIVASMTVR | 796 | Q8IY37 | |
| LCAISIDRYTAVVMP | 121 | P35462 | |
| YPVIMSKRLCCALVT | 131 | Q8NGG4 | |
| SVMAPFVCIIISYLR | 206 | Q8NH93 | |
| CVLVLPMVLIFISYV | 206 | P0C629 | |
| TVYTLVIVPRMLLSL | 71 | Q8NHC4 | |
| MTEAPIVLVTRFLCI | 201 | Q8NGR8 | |
| CYTTVVVPLMLSNIL | 76 | Q8NGQ4 | |
| VIPVLIIIVCYTLMI | 236 | P41145 | |
| VPVLVISVCYSLMIR | 226 | P41146 | |
| SVIDRLLSVIYTVMP | 266 | Q96R54 | |
| LIYVVTVCGNMLIVV | 31 | Q8NH37 | |
| PCLIMISLYVKIFVV | 211 | O14804 | |
| PTRLIATIMVLLCFA | 96 | O95562 | |
| LPTLLIAECVLVYMT | 191 | Q9UIC8 | |
| VCTRKEYLTMSLPEV | 656 | Q6ZNJ1 | |
| LLPLTAMAICYSRIV | 126 | Q96P88 | |
| RILYTDMVACVVPSE | 336 | Q9NY91 | |
| AITADILMYVVIPTR | 441 | Q8IVW8 | |
| ILMYVVIPTRRATAV | 446 | Q8IVW8 | |
| YTTIMRPSVCIGTVV | 131 | Q8NGC5 | |
| ICNPLLYTVIMSRRV | 126 | Q8NH51 | |
| LYTVIMSRRVCQVLV | 131 | Q8NH51 | |
| LVLIAVMLVSRTYCD | 86 | P28288 | |
| MTLCVISIDRYLGIT | 171 | P34969 | |
| PFVIIIVCYTMIILT | 201 | Q9Y271 | |
| QCYIDPSLTVLMVII | 276 | Q6XR72 | |
| SLLLCPATAVIIYRM | 36 | Q9BZL3 | |
| LFVPVTLCMIVVVAT | 91 | P49810 | |
| LCYLPTAGRMTLTVI | 371 | Q6XYQ8 | |
| ILYCVVTSPMLLVAL | 86 | Q9UI14 | |
| TPLYACELCATVMRI | 3371 | Q96JG9 | |
| YILTPEMCVERKSIS | 716 | Q92889 | |
| TIPLVCIYMLSTNIL | 956 | Q7Z2W7 | |
| CVVMVCILLYTTYPL | 321 | Q9Y6M5 | |
| YLVTLPSIRVTQLMT | 1971 | P31629 | |
| MRVYVLITSCDPLRI | 246 | A6NNM8 | |
| PVGVLYIRSCRVLML | 111 | Q9P055 | |
| FLVPMIIVIFCYLRI | 196 | P48039 |